NNVC

NanoViricides (NNVC)

About NanoViricides (NNVC)

NanoViricides, Inc. is a clinical stage company, which engages in the development of nano-biopharmaceutical drugs against viruses. It focuses on anti-viral therapeutics through internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Details

Daily high
$0.93
Daily low
$0.88
Price at open
$0.89
52 Week High
$2.23
52 Week Low
$0.85
Market cap
19.0M
Dividend yield
0.00%
Volume
250,963
Avg. volume
285,372
P/E ratio
-1.73

NanoViricides News

Details

Daily high
$0.93
Daily low
$0.88
Price at open
$0.89
52 Week High
$2.23
52 Week Low
$0.85
Market cap
19.0M
Dividend yield
0.00%
Volume
250,963
Avg. volume
285,372
P/E ratio
-1.73